Variability in response to antihypertensive drug treatment

Hypertension

Volumn 43, Issue 6, 2004, Pages 1166-1167

  Materson, Barry J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART RATE VARIABILITY; HYPERTENSION; PHARMACOGENOMICS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANTIHYPERTENSIVE AGENTS; DRUG RESISTANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM; TETRAHYDROISOQUINOLINES; VARIATION (GENETICS);

EID: 2542421824     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000127916.65346.5c     Document Type: Editorial

References (18)

1. Banerjee D, Materson BJ. Blood pressure-independent impact of antihypertensive agents on cardiovascular and renal disease. Current Hypertension Rep. 2002;4:445-452.
2. Cushman WC, Reda DJ, Perry Jr HM, Williams D, Abdellatif M, Materson BJ for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Arch Intern Med. 2000;160:825-831.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Jones DW, Materson BJ, Oparil S, Wright Jr JT, Roccella EJ, the National High Blood pressure Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood pressure (JNC 7-Complete Version). Hypertension. 2003;42:1206-1252.
4. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Prospective Studies Collaboration. Lancet. 2002;360:1903-1913.
5. Greenberg JA. Removing confounders from the relationship between mortality risk and systolic blood pressure at low and moderately increased systolic blood pressure. J Hypertens. 2003;21:49-56.
6. Mokwe E, Ohmit SE, Nasser SA, Shafi T, Saunders E, Crook E, Dudley A, Flack JM. Determinants of blood pressure response to ACE-inhibitor monotherapy in black and white hypertensives: the ATIME trial. Hypertension. 2004;43:1202-1207.
7. Flack JM, Yunis C, Preisser J, Holmes CB, Mensah G, McLean B, Saunders E, for the ATIME Research Group. The rapidity of drug dose escalation influences blood pressure response and adverse effects burden in patients with hypertension. The Quinapril Titration Interval Management Evaluation (ATIME) Study. Arch Intern Med. 2000;160:1842-1847.
8. Ayman D. Essential hypertension. The diastolic blood pressure: its variability. Arch Intern Med. 1931;48:89-97.
9. Ayman D. An evaluation of therapeutic results in essential hypertension. II. The interpretation of blood pressure reductions. JAMA. 1931;96:2091-2094.
10. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mm Hg. JAMA. 1967;202:116-122.
11. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Low-dose captopril for the treatment of mild to moderate hypertension. I. Results of a 14-week trial. Arch Intern Med. 1984;144:1947-1953.
12. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. JAMA. 1982;248:1996-2003.
13. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
14. Materson BJ, Reda DJ, Cushman WC for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Department of Veterans Affairs single-drug therapy of hypertension study: revised figures and new data. Am J Hypertens. 1995;8:189-192.
15. Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, Anderson RJ for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Age-race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. JAMA. 1998;280:1168-1172.
16. Materson BJ. High blood pressure in African Americans. Arch Intern Med. 2003;163:521-522.
17. Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG; The Hypertension in African Americans Working Group. Management of high blood pressure in African Americans: Consensus statement of the Hypertension in African Americans Working Groups of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525-541.
18. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Racial differences in response to low-dose captopri are abolished by the addition of hydrochlorothiazide. Br J Clin Pharmacol. 1982;14:97s-101s.